A novel tellurium-containing heterocycle, 2H-1,4-benzotellurazin-3(4H)
-one 1 has been prepared by treatment of butyl 2-aminophenyl telluride
2 with either bromoacetic acid or bromoacetyl chloride and subsequent
elimination of butyl bromide from the tellurazinium compound 3 so for
med.